Literature DB >> 22237382

Value of magnetic resonance and ¹⁸FDG PET-CT in predicting tumor response and resectability of primary locally advanced cervical cancer after treatment with intensity-modulated arc therapy: a prospective pathology-matched study.

Katrien Vandecasteele1, Louke Delrue, Bieke Lambert, Amin Makar, Kathleen Lambein, Hannelore Denys, Philippe Tummers, Rudy Van den Broecke, Geert Villeirs, Gert De Meerleer.   

Abstract

OBJECTIVE: To report on the value of magnetic resonance imaging (MRI) and 2-deoxy-2-[18] fluoro-D-glucose positron emission tomography computed tomography (¹⁸FDG PET-CT) in predicting resectability and pathological response of primary locally advanced cervical cancer after neoadjuvant intensity-modulated arc therapy (IMAT) with or without cisplatin (C). METHODS AND MATERIALS: Twenty-seven patients with International Federation of Gynecology and Obstetrics stages IB2 to IVA cervical cancer were treated with IMAT-C followed by extrafascial hysterectomy (EH). All patients received MRI and ¹⁸FDG PET-CT after IMAT-C. The end points of this study were to: 1. Assess the ability of MRI to predict negative surgical margins (R0). 2. Assess the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of MRI in predicting the following situation at the EH specimen: "no residual disease or minimal microscopically visible residual tumor." 3. Assess the sensitivity, specificity, PPV, and NPV value of ¹⁸FDG PET-CT in predicting "no residual viable tumor cells" at the EH specimen.
RESULTS: An R0 resection was obtained in all patients. None of the EH specimens contained macroscopically visible tumor. In 13 patients, no viable tumor cells were found and only 14 had residual microscopic disease. Twenty-four of 27 MRIs were able to correctly predict R0 resection. A negative MRI was 100% predictive for the end point "R0 resection." The specificity and NPV of MRI (end point 2) were 74% and 100%, respectively. No sensitivity or PPV could be calculated. The sensitivity, specificity, PPV, and NPV of ¹⁸FDG PET-CT were 29%, 62%, 44%, and 44%, respectively (end point 3).
CONCLUSIONS: A negative MRI after IMAT-C predicts 100% correctly for R0 resection. The role of FDG PET-CT in predicting viable tumor cells at EH specimen is at least debatable.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22237382     DOI: 10.1097/IGC.0b013e3182428925

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  5 in total

1.  Variability in clinical target volume delineation for intensity modulated radiation therapy in 3 challenging cervix cancer scenarios.

Authors:  Karen Lim; Beth Erickson; Ina M Jürgenliemk-Schulz; David Gaffney; Carien L Creutzberg; Akila Viswanathan; Lorraine Portelance; Sushil Beriwal; Aaron Wolfson; Walter Bosch; Jennifer De Los Santos; Catheryn Yashar; Anuja Jhingran; Mahesh Varia; Issam El Naqa; Bronwyn King; Anthony Fyles
Journal:  Pract Radiat Oncol       Date:  2015-07-02

2.  Tumor radiomic heterogeneity: Multiparametric functional imaging to characterize variability and predict response following cervical cancer radiation therapy.

Authors:  Stephen R Bowen; William T C Yuh; Daniel S Hippe; Wei Wu; Savannah C Partridge; Saba Elias; Guang Jia; Zhibin Huang; George A Sandison; Dennis Nelson; Michael V Knopp; Simon S Lo; Paul E Kinahan; Nina A Mayr
Journal:  J Magn Reson Imaging       Date:  2017-10-16       Impact factor: 4.813

Review 3.  Diagnostic Accuracy of 18F-FDG-PET/CT and MRI in Predicting the Tumor Response in Locally Advanced Cervical Carcinoma Treated by Chemoradiotherapy: A Meta-Analysis.

Authors:  Sharareh Sanei Sistani; Fateme Parooie; Morteza Salarzaei
Journal:  Contrast Media Mol Imaging       Date:  2021-03-02       Impact factor: 3.161

4.  Effects of Treatment of Uterine Cervical Carcinoma Monitored by Magnetic Resonance Imaging - Sarajevo Experience.

Authors:  Amela Sofic; Azra Husic-Selimovic; Nermina Beslic; Azra Rasic; Dzenana Begic; Anja Tomic-Cica; Nejira Imsirevic
Journal:  Acta Inform Med       Date:  2017-03

Review 5.  A practical review of magnetic resonance imaging for the evaluation and management of cervical cancer.

Authors:  Emma C Fields; Elisabeth Weiss
Journal:  Radiat Oncol       Date:  2016-02-02       Impact factor: 3.481

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.